​Vivo Efficacy of Blood stable Thiobenzamides​ ​

The NIH Office of Acquisitions seeks a firm‑fixed‑price vendor to provide in‑vivo efficacy testing of blood‑stable thiobenzamides using mouse disease models. The scope includes 20 mouse model setups, disease induction, treatment administrations, viral load monitoring (BSL‑3), sample collection, immunophenotyping (baseline and post‑stimulation), and project management/reporting deliverables. Vendors must submit unit and total pricing, shipping, delivery terms, and product details. Evaluation will consider technical merit, past performance, and price, with technical factors outweighing cost. The contract ceiling is $350,000. • Perform mouse model creation, disease induction, and treatment (20 each). • Conduct BSL‑3 viral load monitoring, sample collection, and immunophenotyping (20 each). • Provide project management updates and a standard final report. • Submit a complete commercial proposal per FAR 12.603 requirements. • Must be registered in SAM and include UEI and size certifications.